| P2093 | author name string | Vibhudutta Awasthi | |
| | Okhil K Nag | |
| P2860 | cites work | Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials | Q46746997 |
| | Hydrophobically derivatized hyperbranched polyglycerol as a human serum albumin substitute | Q46808486 |
| | New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes | Q46820609 |
| | Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age. | Q46961552 |
| | Biocompatibility testing of branched and linear polyglycidol. | Q46984573 |
| | Peptide-mediated targeting of liposomes to tumor cells | Q47591442 |
| | Poly(ethylene oxide) Grafted to Silicon Surfaces: Grafting Density and Protein Adsorption | Q47781299 |
| | Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. | Q49238618 |
| | Histidine-conjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin. | Q51166727 |
| | Molecular simulation study of water interactions with oligo (ethylene glycol)-terminated alkanethiol self-assembled monolayers. | Q51612944 |
| | Interactions of liposomes with serum proteins. | Q52494811 |
| | Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. | Q53003630 |
| | Phosphorylcholine-based polymers and their use in the prevention of biofouling. | Q54042925 |
| | Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon | Q56897495 |
| | Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity | Q57184466 |
| | Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery | Q57189516 |
| | Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential | Q24657256 |
| | Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers | Q27496024 |
| | PEGylation, successful approach to drug delivery | Q28278538 |
| | Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting | Q30456053 |
| | Oxidation of polyethylene glycols by alcohol dehydrogenase | Q30459793 |
| | Hydration of polyethylene glycol-grafted liposomes | Q30538937 |
| | Lipopolymers from new 2-substituted-2-oxazolines for artificial cell membrane constructs | Q33215134 |
| | Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine). | Q33219913 |
| | Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles | Q33500698 |
| | Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: toward multifunctional stealth liposomes | Q33528053 |
| | Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors | Q33649082 |
| | Zero-order interfacial enzymatic degradation of phospholipid tubules | Q33907024 |
| | Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic | Q33911056 |
| | Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting | Q33987573 |
| | Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications | Q34103124 |
| | New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates | Q34168201 |
| | Nanoparticle delivery of cancer drugs. | Q34213157 |
| | Investigation of the hydration of nonfouling material poly(sulfobetaine methacrylate) by low-field nuclear magnetic resonance | Q34237251 |
| | Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 |
| | Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes | Q34335325 |
| | Pegylation: a novel process for modifying pharmacokinetics | Q34340198 |
| | A biomimetic lipid library for gene delivery through thiol-yne click chemistry | Q34383564 |
| | Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. | Q34407520 |
| | Quantitative evaluation of bioorthogonal chemistries for surface functionalization of nanoparticles. | Q34478415 |
| | Poly(2-oxazolines) in biological and biomedical application contexts | Q34695315 |
| | Liposome clearance | Q34995185 |
| | Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). | Q34995189 |
| | Lipid membranes with grafted polymers: physicochemical aspects | Q35209161 |
| | Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment | Q35488326 |
| | Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 |
| | "Clickable", polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositions | Q35606153 |
| | Sterically stabilized liposomes | Q35756716 |
| | Spontaneous liposome formation induced by grafted poly(ethylene oxide) layers: theoretical prediction and experimental verification | Q35785571 |
| | Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery | Q36161132 |
| | Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity | Q36248358 |
| | Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles | Q36440766 |
| | The role of complement in biomaterial-induced inflammation | Q36564335 |
| | Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide | Q36687313 |
| | Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy | Q36740474 |
| | Complement and coagulation: strangers or partners in crime? | Q36750470 |
| | Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo | Q36792020 |
| | Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time | Q36800814 |
| | Antibody-targeted liposomes in cancer therapy and imaging | Q37076367 |
| | Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives | Q37774596 |
| | Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor | Q37811459 |
| | Immunotherapy with monomethoxypolyethylene glycol modified allergens | Q37922476 |
| | Correlation of fixed aqueous layer thickness around PEG-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes | Q37950398 |
| | Liposomal drug delivery systems: from concept to clinical applications | Q38049376 |
| | Poly(N-vinylpyrrolidone)-modified surfaces for biomedical applications. | Q38065133 |
| | Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome | Q39198874 |
| | Superhydrophilic zwitterionic polymers stabilize liposomes | Q39316553 |
| | Changes in the lipid dynamics of liposomal membranes induced by poly(ethylene glycol): free volume alterations revealed by inter- and intramolecular excimer-forming phospholipid analogs | Q39461755 |
| | In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines). | Q39538256 |
| | Poly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranes | Q39651174 |
| | Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992). | Q40204479 |
| | Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction. | Q40263083 |
| | Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates | Q40427856 |
| | Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant Conjugates | Q40437361 |
| | Ligand-targeted liposomes | Q40762762 |
| | Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects | Q40785126 |
| | Prolongation of liposome circulation time by various derivatives of polyethyleneglycols | Q41161280 |
| | Enzyme-induced shedding of a poly(amino acid)-coating triggers contents release from dioleoyl phosphatidylethanolamine liposomes | Q41623410 |
| | Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours | Q41637144 |
| | New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine | Q41692785 |
| | Polyethylene glycol-coated biocompatible surfaces | Q41745047 |
| | The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. | Q42031050 |
| | Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo | Q42042312 |
| | Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate | Q42126581 |
| | Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro | Q42746832 |
| | Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure | Q42923743 |
| | Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes | Q43123474 |
| | (99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours | Q43217480 |
| | Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics | Q43245633 |
| | Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success | Q43563654 |
| | Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats | Q43672651 |
| | Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. | Q43785244 |
| | Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes | Q43973334 |
| | Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome | Q43983925 |
| | Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin | Q44262364 |
| | Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits | Q44320521 |
| | Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies | Q44326733 |
| | Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine | Q44586379 |
| | Direct 99mTc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies | Q44650585 |
| | A Novel Family ofl-Amino Acid-Based Biodegradable Polymer−Lipid Conjugates for the Development of Long-Circulating Liposomes with Effective Drug-Targeting Capacity | Q44660389 |
| | Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins | Q44934983 |
| | Stability of liposomal formulations in physiological conditions for oral drug delivery | Q44938782 |
| | Experimental polymer storage disease in rabbits. An approach to the histogenesis of sphingolipidoses | Q45109885 |
| | A photo-triggerable drug carrier based on cleavage of PEG lipids by photosensitiser-generated reactive singlet oxygen. | Q45218363 |
| | Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery | Q45264759 |
| | The encapsulation and release of guanosine from PEGylated liposomes. | Q45974645 |
| | Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. | Q46070244 |
| | Molecular simulation studies of protein interactions with zwitterionic phosphorylcholine self-assembled monolayers in the presence of water | Q46438052 |
| | Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives | Q46460581 |
| | Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes. | Q46477273 |
| | Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer | Q46515132 |
| | Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes | Q46576610 |
| | Complement activation by PEGylated liposomes containing prednisolone | Q46723086 |
| | Poly(ethylene glycol)-Modification of the Phospholipid Vesicles by Using the Spontaneous Incorporation of Poly(ethylene glycol)-Lipid into the Vesicles | Q57832863 |
| | Lipid chain length effect on the phase behaviour of PCs/PEG:2000-PEs mixtures. A spin label electron spin resonance and spectrophotometric study | Q59133691 |
| | The chemical modification of liposome surfaces via a copper-mediated [3 + 2] azide–alkyne cycloaddition monitored by a colorimetric assay | Q61399932 |
| | Development of Non-Phospholipid Liposomes Containing a High Cholesterol Concentration | Q61644815 |
| | Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum | Q61644926 |
| | Protein adsorption from human plasma is reduced on phospholipid polymers | Q67868736 |
| | Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma | Q68068836 |
| | Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium | Q68169480 |
| | Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues | Q69608569 |
| | Antibody dependent, complement mediated liver uptake of liposomes containing GM1 | Q70980666 |
| | Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes | Q71198019 |
| | Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors | Q71298948 |
| | Response of dogs to repeated intravenous injection of polyethylene glycol 4000 with notes on excretion and sensitization | Q71755814 |
| | Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice | Q72096757 |
| | The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ | Q72148737 |
| | Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo | Q72696911 |
| | Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia | Q72834303 |
| | Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol) | Q73148890 |
| | Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? | Q73253522 |
| | Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin | Q73293449 |
| | Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin | Q73837227 |
| | Bone marrow failure and myelofibrosis in a case of PVP storage disease | Q74019386 |
| | Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes | Q74249247 |
| | Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins | Q74524730 |
| | Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine | Q74801955 |
| | Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics | Q75245788 |
| | Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute | Q77905198 |
| | Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production | Q79301050 |
| | Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes | Q79404069 |
| | Characterization of novel mixed polyethyleneglycol modified liposomes | Q79486528 |
| | Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration | Q79558288 |
| | Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy? | Q79614630 |
| | The toxicology of the polyethylene glycols | Q80725909 |
| | Polymerized surfactant vesicles: novel membrane mimetic systems | Q81026631 |
| | Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression | Q81747045 |
| | Platelets directed liposomes for the delivery of streptokinase: development and characterization | Q82082516 |
| | Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery | Q83126421 |
| | Decreased material-activation of the complement system using low-energy plasma polymerized poly(vinyl pyrrolidone) coatings | Q83757312 |
| | Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods | Q84528928 |
| | Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies | Q84545804 |
| | Change in the character of liposomes as a drug carrier by modifying various polyethyleneglycol-lipids | Q86884007 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P304 | page(s) | 542-569 | |
| P577 | publication date | 2013-10-25 | |
| P1433 | published in | Pharmaceutics | Q27723332 |
| P1476 | title | Surface engineering of liposomes for stealth behavior | |
| P478 | volume | 5 | |